ACT therapy for chronic migraine disability
Part of Brain & nervous system clinical trials.
This study tests whether Acceptance and Commitment Therapy (ACT), a type of talk therapy that helps you accept difficult thoughts and feelings, can reduce disability caused by chronic migraine. You will be placed in one of two groups to compare ACT with your usual care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are diagnosed with chronic migraine and are being treated at the Graham Headache Center.
- You are willing to try a new kind of therapy called Acceptance and Commitment Therapy (ACT), even if you are assigned to a different group.
- You have access to a phone, computer, or tablet to take part in this online program.
- You do not have a major depression or other serious psychiatric condition.
- You have never tried mindfulness or meditation practices before.
- You speak English fluently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an online mindfulness therapy program (like guided meditation and relaxation) to see if it can help reduce migraine pain and stress in people who have both chronic migraines and a history of difficult childhood experiences. The sessions are held online in the evening.
This study tests different behavioral (non-medication) approaches to help manage chronic migraine. You'll work with researchers to find which approach works best for you, with the option to switch strategies if needed.
This trial tests a behavioral (talk/skills-based) program to help people with chronic migraine. It may help reduce migraine frequency or improve day-to-day coping.
This study looks at ways to help children and teens with migraine headaches by testing a care approach that includes access to evidence-based treatment. It may help if your child has frequent migraine headaches and is starting (or not already on) certain migraine-preventive medicines.
This study looks at how preventive treatments (botulinum toxin type A or anti-CGRP antibodies) affect thinking, memory, and quality of life in adults with hard-to-treat migraines. It aims to see if these treatments help more than just reducing headache days.
This trial studies a mind-body balance approach to help reduce symptoms and disability from pediatric migraine. You may join if your child has migraine headaches and can follow study routines, including keeping a headache diary.
Hear when a new Chronic Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.